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ABSTRACT
Introduction: The vast majority of older French 
adults exhibit some degree of hypovitaminosis 
D. The objective of this cross-sectional study 
was to determine the rate and the reasons for 
vitamin D prescription among older French 
adult community dwellers. Methods: Vitamin 
D supplementation was systematically assessed 
among 1876 French community dwellers aged 
≥65 years. Theoretical indications for vitamin D 
supplementation were collected, ie, the causes 
of hypovitaminosis D (older age, male gender, 
kidney failure, undernutrition, polymorbidity) 
or its clinical complications (vertebral or non-
vertebral fractures, gait disturbances, history 
of falls, muscle weakness, and cognitive 
impairment). Results: In total, 13.8% of the 
subjects (n=258) had vitamin D supplementation. 
They were more often malnourished (P=0.002), 
exhibited polymorbidity (P<0.001) and muscle 
weakness (P<0.001), and had a history of 
vertebral fractures (P<0.001), non-vertebral 
fractures (P<0.001), and accidental falls 
(P<0.001). Vitamin D supplementation was 
explained by the number of complications 
of hypovitaminosis D (odds ratio [OR]=1.61, 
P<0.001) including vertebral fractures (adjusted 
OR=1.49, P=0.007), non-vertebral fractures 
(adjusted OR=1.74, P=0.026), accidental falls 
(adjusted OR=1.44, P=0.015), and muscle 
weakness (adjusted OR=3.96, P<0.001), but not 
by the number of causes of hypovitaminosis 
D (P=0.464). Conclusion: Even if vitamin D 
supplementation is selected well for appropriate 
patients, the rate of supplementation remains 
insufficient in France, and probably comes 
too late, ie, at the stage of complications of 
hypovitaminosis D. These findings should 
encourage physicians to supplement vitamin D 
more often and sooner in their elderly patients.
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INTRODUCTION 
Between 70% to 90% of French community-
dwelling adults aged ≥65 years exhibit 
some degree of hypovitaminosis D.1-3
Hypovitaminosis D is associated with poor 
health outcomes among older adults including 
bone disease, neuromuscular impairments, 
and gait disturbances.4-6 Prevention of these 
clinical events depends on the correction of 
vitamin D status.7 It is now acknowledged 
that the inadequate vitamin D intakes 
in elderly subjects may not be efficiently 
handled with dietary measures or food 
supplementation alone.7 This highlights the 
central role of physician-prescribed vitamin D 
supplementation, especially in France where 
food fortification and one-a-day vitamins 
supply minor intakes of vitamin D.8 Although 
there is a growing body of literature on 
vitamin D and aging, little is known about the 
rate of supplementation in France, and about 
the reasons that lead primary care physicians 
to prescribe vitamin D supplementation to 
their elderly patients. The objective of our 
study was to determine whether the rate of 
supplementation covered the needs of older 
French community-dwelling adults, and to 
identify the clinical reasons for vitamin D 
prescription among this population.
MATERIALS AND METHODS
Subjects
Between July 2008 and October 2009, 1876 
community-dwelling subjects aged ≥65 years 
(mean age 70.3±0.2 years; 50.4% men) were 
recruited in eight French health centers 
localized in Eastern France during a free 
medical examination. Exclusion criteria for this 
cross-sectional study included age <65 years, 
institutionalization, the inability to understand 
and speak French, and a history of acute medical 
illness during the past month.
Clinical Assessment
Vitamin D supplementation was noted from 
the primary care physician’s prescription, 
whatever the dosage schedule or route of 
administration, and regardless of the date 
of commencement.
We considered as theoretical indications for 
vitamin D supplementation either the causes 
of hypovitaminosis D (ie, older age >70 years, 
male gender, kidney failure, undernutrition, 
polymorbidity)1,9 or its clinical complications 
(ie, vertebral or non-vertebral fractures, gait 
disturbances, previous falls, muscle weakness, 
and cognitive impairment).4-6
A systematic standardized questionnaire 
gathered information about the number of 
drugs taken per day (≥five drugs excluding 
vitamin D defined polymorbid conditions), 
height at 20 years of age, history of accidental 
falls over the past year, and non-vertebral 
fractures. History of vertebral fractures was 
defined by the loss of at least 3 cm of height 
since the age of 20 years,10 and undernutrition 
by a body mass index <21 kg/m2.11 Gait 
disturbances were defined by a timed up-and-go 
test ≥14 seconds,12 and muscle weakness as 
being in the worst tertile of handgrip strength 
measured with a handheld dynamometer 
(Jamar, SammonsPreston, Bolingbrook, IL). 
Cognitive impairment was defined by impaired 
performance on the clock-drawing test.13
Finally, serum creatinine concentration was 
measured to assess renal function. Our budget 
was limited, and only the first 415 patients 
had a blood test. Kidney failure was defined 
by creatinine clearance <60 mL/min using the 
Cockcroft formula.
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Statistics
The subjects’ baseline characteristics were 
summarized using means and standard 
deviations or frequencies and percentages, as 
appropriate. Normality of data distribution was 
checked using a skewness-kurtosis test. As the 
number of patients included was higher than 40 
for each group, no transformations were applied 
to the variables of interest. Comparisons between 
groups were performed using the Chi-square test 
or the independent samples t-test, as appropriate. 
Table 1. Characteristics and comparison of the subjects (n=1876) separated into two groups based on vitamin D supplementation.
   Proportion (%) Vitamin D No vitamin D  
  Total cohort  of vitamin D  supplementation supplementation 
  (n=1876) supplementation (n=258) (n=1618) P-value*
Causes of hypovitaminosis D     
 Age >70, n (%) 743 (39.6) 25.8 192 (74.4) 551 (34.1) 0.146
 Male, n (%) 946 (50.4) 3.3 29 (11.2) 917 (56.7) <0.001
 Kidney failure,† n (%) (n=415) 149 (35.9) 14.1 21 (36.2) 118 (33.1) 0.926
 Undernutrition,‡ n (%) 126 (6.7) 23.0 29 (11.2) 97 (6.0) 0.002
 Polymorbidity,§ n (%) 451 (24.0) 20.6 93 (36.0) 358 (22.1) <0.001
Clinical complications of hypovitaminosis D     
 History of vertebral fracture,|| n (%) 890 (47.4) 18.3 163 (63.2) 727 (44.9) <0.001
 History of non vertebral fracture,¶ n (%) 108 (5.8) 29.6 32 (12.4) 76 (4.7) <0.001
 Gait disturbances,# n (%) 178 (9.5) 17.4 31 (12.0) 147 (9.1) 0.136
 History of accidental falls,¶ n (%) 714 (38.1) 19.5 139 (53.9) 575 (35.5) <0.001
 Weakness,** n (%) 615 (33.0) 27.0 166 (64.8) 449 (28.0) <0.001
 Cognitive impairment,†† n (%) 483 (25.7) 14.1 68 (26.4) 415 (25.6) 0.809
Indications for vitamin D supplementation     
 Total number (/11), mean±SD  2.97±0.08 - 3.67±0.88 2.97±0.08 0.440
 Number of causes of hypovitaminosis  1.55±0.51 - 2.00±0.58 1.55±0.05 0.460 
 D (/5), mean±SD  
 Number of clinical complications of  1.59±003 - 2.32±0.08 1.48±0.03 <0.001 
 hypovitaminosis D (/6), mean±SD  
SD, standard deviation.
*Comparisons of subjects with vitamin D supplementation with subjects without vitamin D supplementation based on the 
independent samples t-test or Chi-square test, as appropriate.
†Creatinine clearance <60 mL/min; creatinine clearance calculated using Cockcroft formula (ie, [(140-age years) x weight 
kg /creatinine mol/l] x1.04 for women, and x1.25 for men).
‡Body mass index <21 kg/m2.
§Defined by a number of drugs taken per day >4 after subtraction of vitamin D supplementation.
||Loss of at least 3 cm of height since the age of 20 years.
¶Obtained from a systematic standardized questionnaire.
#Timed up-and-go test ≥14 seconds.
**Worst tertile of handgrip strength; handgrip strength was calculated as the mean value of 3 repeated strength 
measurements of the dominant upper limb.
††Impaired clock-drawing test.
P significant (ie, P< 0.05) indicated in bold.
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Secondly, univariate and multiple (ie, adjusted 
model, and stepwise backward model) 
logistic regressions were used to examine the 
association between the indications for vitamin 
D supplementation (independent variable) 
and vitamin D supplementation (dependent 
variable) while adjusting for the same category 
of indications (ie, causes or complications 
of hypovitaminosis D). P-values <0.05 were 
considered significant. Statistical analyses were 
performed with the use of the SPSS software 
(version 17.0; SPSS, Inc., Chicago, IL).
Standard Protocol Approvals, Registrations, 
and Patient Consents
Participants in the study were included only 
after having given their written informed 
consent for research. The study was conducted 
in accordance with the ethical standards set 
forth in the Helsinki Declaration (1983). The 
entire study protocol was approved by the local 
Ethical Committee.
RESULTS
Among our cohort of community-dwelling 
older adults, 13.8% (n=258, 11.2% male) had 
vitamin D supplementation. They were more 
often malnourished (P=0.002), and more often 
exhibited polymorbidity (P<0.001) and muscle 
weakness (P<0.001) (Table 1). In addition, they 
more often had a history of vertebral fractures 
(P<0.001), non-vertebral fractures (P<0.001), 
and accidental falls (P<0.001) (Table 1). Table 1 
also shows the proportion of participants 
receiving vitamin D supplementation 
according to potential indications. The rate of 
supplementation was low in each case, reaching 
only 29.6% in best-case scenario.
Table 2 displays the results of logistic 
regressions. Vitamin D supplementation was 
explained by a history of vertebral fractures 
(odds ratio [OR]=1.49, P=0.007), non-vertebral 
fractures (OR=1.74, P=0.026) and accidental falls 
(OR=1.44, P=0.015), and by muscle weakness 
(OR=3.96, P<0.001) and polymorbidity (OR=9.29, 
P=0.070) (Table 2). Finally, logistic regression 
showed that the more complications of 
hypovitaminosis D there were, the more vitamin 
D supplementation we observed (OR=1.61 [95% 
CI: 1.46-1.78], P<0.001) although the number of 
causes of hypovitaminosis D was not significantly 
associated with supplementation (OR=1.47 [95% 
CI: 0.52-4.13], P=0.464).
DISCUSSION
Our results showed that the rate of vitamin D 
supplementation was low among older French 
community-dwelling adults, reaching only 
13.8% of the cohort, and ranging between 
3.3% and 29.6% of subjects exhibiting some 
indications for supplementation. This result 
was coherent with previous research that found 
a 13% rate of supplementation among older 
Belgian adults living in urban areas,14 or a 15% 
rate of treatment among Dutch patients one 
year after an osteoporotic fracture.15
Even if this quantitative aspect was 
much lower than the 70% to 90% rate of 
hypovitaminosis D and should challenge the 
French health policy, our findings also showed 
that older adults receiving supplementation 
were well-chosen as illustrated by strong 
associations of theoretical indications for 
vitamin D supplementation with concrete 
supplementation (Table 2). Nevertheless, it 
seems that primary care physicians prescribed 
vitamin D too late, as not the causes but the 
complications of hypovitaminosis D mainly lead 
to supplementation (Table 3). In addition, we 
found that clinical criteria for supplementation 
decisions were the most recognized (ie, history 
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Table 2. Univariate and multiple* logistic regressions showing the cross-sectional association between vitamin D supplementation 
(dependent variable) and the different indications for vitamin D supplementation (independent variables) (n=1876).
 Vitamin D supplementation
 Unadjusted model Adjusted model* Stepwise backward model*
  OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value
Causes of  
hypovitaminosis D          
 Age >70 years 4.63 0.48-44.89 0.186 3.33 0.28-40.07 0.344 - - -
 Male 0.04 0.02-0.06 <0.001 0.39 0.03-4.45 0.446 - - -
 Kidney failure† 0.89 0.08-9.92 0.926 0.64 0.05-7.87 0.730 - - -
 Undernutrition‡ 1.99 1.28-3.08 0.002 0.00 0.00- 0.998 - - -
 Polymorbidity§ 1.98 1.50-2.63 <0.001 8.69 0.77-98.85 0.081 9.29 0.83-103.80 0.070
Clinical complications of  
hypovitaminosis D         
 History of vertebral  2.10 1.60-2.76 <0001 1.55 1.16-2.08 0.003 1.49 1.12-2.00 0.007 
 fracture|| 
 History of non  2.87 1.86-4.44 <0.001 1.71 1.04-2.79 0.033 1.74 1.07-2.84 0.026 
 vertebral fracture 
 Gait disturbances¶ 1.37 0.91-2.06 0.137 0.81 0.52-1.27 0.354 - - -
 History of accidental  2.12 1.63-2.76 <0.001 1.47 1.09-1.97 0.011 1.44 1.07-1.93 0.015 
 falls# 
Weakness** 4.75 3.59-6.28 <0.001 4.07 3.04-5.46 <0.001 3.96 2.96-5.29 <0.001
Cognitive impairment†† 1.04 0.77-1.40 0.809 0.84 0.61-1.16 0.283 - - -
OR, odds ratio; CI, confidence interval.
*Separated analyses with adjustment for the same category of indications for vitamin D supplementation (ie, causes or 
complications of hypovitaminosis D).
†Creatinine clearance <60mL/min.
‡Body mass index <21 kg/m2.
||Defined by a number of drugs taken per day >4 excluding vitamin D.
§Loss of at least 3 cm of height since the age of 20 years.
¶Timed up-and-go test ≥14 seconds.
#Obtained from a systematic standardized questionnaire.
**Worst tertile of handgrip strength of the dominant upper limb.
††Impaired clock-drawing test performance.
OR significant (ie, P<0.05) indicated in bold.
Table 3. Logistic regression showing the cross-sectional association between vitamin D supplementation (dependent 
variable) and the number of indications for vitamin D supplementation (independent variables) (n=1876).
  Vitamin D supplementation
  OR 95% CI P-value
Total number of indications for vitamin D supplementation (/11) 1.29 0.67-2.48 0.443
Number of causes of hypovitaminosis D (/5) 1.47 0.52-4.13 0.464
Number of clinical complications of hypovitaminosis D (/6) 1.61 1.46-1.78 <0.001
OR, odds ratio; CI, confidence interval.
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of fractures and falls, muscle weakness),4
while newer criteria such as cognitive 
impairment5 were not associated with vitamin 
D supplementation. The main reasons could be 
a failure in communication campaigns, as well 
as a delayed change in prescribing behavior. 
Limitations of this study included the lack 
of measurement of 25-hydroxyvitamin D 
concentration, which would have confirmed the 
indication for supplementation. Nevertheless, 
the fact that 77.6% of studied subjects presented 
with at least one clinical manifestation of 
hypovitaminosis D (which was concordant with 
the prevalence of hypovitaminosis D in older 
French community-dwellers1-3) justified our 
approach and confirmed the representativeness 
of our cohort. In addition, we did not assess the 
dosage of vitamin D supplementation, although 
it has been suggested that there is a vitamin D 
dosage threshold below which supplements are 
insufficient in the elderly.16 Further studies are 
needed to determine the rate of elderly individuals 
receiving at least 800 UI of vitamin D per day.
CONCLUSION
In conclusion, even if vitamin D supplementation 
is selected well for appropriate patients, the 
rate of supplementation remains insufficient 
in France, and probably comes too late, ie, at 
the stage of complications of hypovitaminosis 
D. These findings should encourage primary 
care physicians to supplement more often and 
sooner in their elderly patients. 
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